Selected Publications

 
  1. Rosenblum, M, Liu H, Yen E.(2014) "Optimal Tests of Treatment Effects for the Overall Population and Two Subpopulations in Randomized Trials, Using Sparse Linear Programming” Journal of the American Statistical Association (Theory and Methods). In Press. [LINK]


  1. Rosenblum M. (2013) “Confidence intervals for the selected population in randomized trials that adapt the population enrolled” Biometrical Journal. 55(3):322-340. [LINK]


  1. Rosenblum M. (2011) “Consonant Multiple Testing Procedures for Subpopulation Treatment Effects in Randomized Trials” Johns Hopkins University, Department of Biostatistics Working Papers.  Working Paper 236. [LINK]


  1. Rosenblum M, van der Laan MJ. (2011) “Optimizing Randomized Trial Designs to Distinguish  which Subpopulations Benefit from Treatment” Biometrika, 98(4): 845-860. [LINK]


  1. Rosenblum M, van der Laan MJ. (2010) “Simple, Efficient Estimators of Treatment Effects in Randomized Trials Using Generalized Linear Models to Leverage Baseline Variables” The International Journal of Biostatistics, 6(1): Article 13. [LINK]


  1. Shiboski S, Rosenblum M, Jewell N. (2010) “The Impact of Secondary Condom Interventions on the Interpretation of Results from HIV Prevention Trials” Statistical Communications in Infectious Diseases, 2(1): Article 2. [LINK]


  1. Rosenblum M, van der Laan MJ. (2010) “Targeted Maximum Likelihood Estimation of the Parameter of a Marginal Structural Model” International Journal of Biostatistics, 6(2): Article 19. [LINK]


  1. Rosenblum M, Jewell NP, van der Laan, MJ, Shiboski S, van der Straten A, Padian N. (2009) “Analyzing Direct Effects in Randomized Trials with Secondary Interventions: An Application to HIV Prevention Trials” Journal of the Royal Statistical Society: Series A, (Statistics in Society), 172(2): 443-465(23). [LINK]

  2. Slides from talk at Fred Hutchinson Cancer Research Center on this work. [PDF]

  3. Rosenblum M, van der Laan MJ. (2009) “Confidence Intervals for the Population Mean Tailored to Small Sample Sizes, with Applications to Survey Sampling” International Journal of Biostatistics, 5(1): Article 4. [LINK]


  1. Rosenblum M, Deeks SG, van der Laan M, Bangsberg DR. (2009) “The Risk of Virologic Failure Decreases with Duration of HIV Suppression, at Greater than 50% Adherence to Antiretroviral Therapy” PLoS ONE, 4(9): e7196. [LINK]


  1. Rosenblum M, van der Laan MJ. (September 2009) “Using Regression Models to Analyze Randomized Trials: Asymptotically Valid Hypothesis Tests Despite Incorrectly Specified Models” Biometrics, 65(3): 937-945. [LINK]

  2. Technical Report Version of Paper [PDF]

  3. Slides from a talk at Berkeley Statistics Colloquium on this work. [PDF]


  1. Padian N, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Montgomery ET, Fancher H, Cheng H, Rosenblum M, van der Laan MJ, Jewell N, McIntyre J, the MIRA team. (2007) “Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial” The Lancet, 370(9583): 251-261. [LINK]